EUVIMEDEUVIMED entdecken
LeserbriefKommentar

Reply to: Towards causal validation and clinical translation of the PAK2–fibroblast axis in idiopathic pulmonary fibrosis

Yuta Hirano, Masahiro Yoshida iD, Naoaki Watanabe, Jun Araya, Yusuke Yamamoto, Yu Fujita

European Respiratory Journal · 2026-03 · 67 (3) · 2502353

DOI: 10.1183/13993003.02353-2025 ↗

Kurz gefasst

Leserbrief in der Zeitschrift European Respiratory Journal, online erschienen am 19.03.2026. Verfasst von Yuta Hirano und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Respiratory Diseases, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan. Die Arbeit nennt 10 Literaturangaben. Gefördert von: EVerMed Inc., Japan Society for the Promotion of Science, Mochida Memorial Foundation for Medical and Pharmaceutical Research.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Division of Respiratory Diseases, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan.
  • Laboratory of Integrative Oncology, National Cancer Center Research Institute, Tokyo, Japan.
  • These authors contributed equally to this work.
  • Division of Respiratory Diseases, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan yuugot@jikei.ac.jp.
  • Division of Next-generation Drug Development Research, Research Center for Medical Sciences, The Jikei University School of Medicine, Tokyo, Japan.

ORCID-Profile: Masahiro Yoshida

Förderung

  • EVerMed Inc.
  • Japan Society for the Promotion of Science
  • Mochida Memorial Foundation for Medical and Pharmaceutical Research
  • GlaxoSmithKline Japan
  • Japanese Respiratory Society

Zitieren

APA

Hirano, Y., Yoshida, M., Watanabe, N., Araya, J., Yamamoto, Y., & Fujita, Y. (2026). Reply to: Towards causal validation and clinical translation of the PAK2–fibroblast axis in idiopathic pulmonary fibrosis. European Respiratory Journal, 67(3), 2502353. https://doi.org/10.1183/13993003.02353-2025

Vancouver

Hirano Y, Yoshida M, Watanabe N, Araya J, Yamamoto Y, Fujita Y. Reply to: Towards causal validation and clinical translation of the PAK2–fibroblast axis in idiopathic pulmonary fibrosis. European Respiratory Journal. 2026;67(3):2502353. doi:10.1183/13993003.02353-2025

BibTeX
@article{Hirano2026,
  author = {Hirano, Yuta and Yoshida, Masahiro and Watanabe, Naoaki and Araya, Jun and Yamamoto, Yusuke and Fujita, Yu},
  title = {Reply to: Towards causal validation and clinical translation of the PAK2–fibroblast axis in idiopathic pulmonary fibrosis},
  journal = {European Respiratory Journal},
  year = {2026},
  volume = {67},
  number = {3},
  pages = {2502353},
  doi = {10.1183/13993003.02353-2025}
}
Kostenlos starten →